Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.5%

2 terminated out of 16 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (10)
P 2 (1)
P 4 (1)

Trial Status

Completed6
Unknown6
Terminated2
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
Showing all 16 trials

Research Network

Activity Timeline